Back/Quest Diagnostics Introduces AI Companion for Enhanced Patient Engagement and Health Insights
health·March 3, 2026·dgx

Quest Diagnostics Introduces AI Companion for Enhanced Patient Engagement and Health Insights

ED
Editorial
Cashu Markets·2 min read
TL;DR
  • Quest Diagnostics introduces the AI Companion in the MyQuest app to help patients understand lab test results.
  • The tool analyzes lab data to identify health trends and enhance patient engagement with healthcare providers.
  • Quest AI Companion prioritizes privacy, allowing patients to utilize AI without compromising their personal health information.

Unlocking Health Insights: Quest Diagnostics Launches AI Companion

Quest Diagnostics, a frontrunner in diagnostic information services, introduces the Quest AI Companion, an innovative AI-powered chat feature within the MyQuest app and portal. This tool is designed specifically to aid patients in understanding and acting on their laboratory test results collaboratively with their healthcare providers. By offering personalized explanations of test results while safeguarding patient privacy, Quest AI Companion operates in a secure, HIPAA-compliant environment. This latest development addresses a pressing need among patients for simplified health insights, ultimately encouraging more informed discussions between patients and healthcare professionals.

The AI Companion analyzes up to five years of lab data to detect trends and identify potential health risks, a feature aimed at enhancing patient engagement. Nicole Antonson, vice president of digital solutions and interoperability at Quest Diagnostics, emphasizes that this initiative empowers individuals to interact more meaningfully with their health data. By demystifying complex medical terminology and lab values, the tool enables users to better understand their health status and to formulate pertinent questions for their healthcare providers. This proactive approach aims to foster dialogue and collaboration, leading to improved health outcomes.

Despite the rapid integration of artificial intelligence into healthcare, an attendant challenge remains: patient apprehensions regarding data privacy. A recent Quest survey reveals that while there is considerable interest in AI applications, many individuals are deterred by potential risks associated with public AI platforms. To address these concerns, Dr. Yuri Fesko, senior vice president at Quest Diagnostics, underscores the importance of privacy in patient engagements, stating, "People want to understand their lab data, but not everyone feels comfortable uploading their health data to public AI platforms." With Quest AI Companion, Quest Diagnostics aims to bridge this gap, allowing patients to utilize AI functionalities without compromising their personal health information.

Additionally, the launch of the AI Companion aligns with the broader trend of healthcare organizations embracing digital health solutions. As technology continues to advance, tools like Quest AI Companion herald a future where patients can navigate their health journeys more effectively. The focus remains on customizing patient experiences, ensuring that vital lab information is readily available and comprehensible, ultimately driving better health management.

As Quest Diagnostics implements these cutting-edge advancements, it underscores its commitment to enhancing patient engagement and accessibility in healthcare, marking a significant stride in the integration of AI within diagnostics.

Cashu Markets
Cashu
Markets

By Cashu Markets. Providing market news, analysis, and research for investors worldwide.

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Markets is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Markets is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Markets and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Cashu Markets
Cashu
Markets

Setting up your session...